Andrew R. Tee
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Tuberous Sclerosis Complex Research, Polyamine Metabolism and Applications, Neurofibromatosis and Schwannoma Cases, Neuroblastoma Research and Treatments
Most-Cited Works
- → Identification of the Tuberous Sclerosis Complex-2 Tumor Suppressor Gene Product Tuberin as a Target of the Phosphoinositide 3-Kinase/Akt Pathway(2002)1,548 cited
- → Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb(2003)1,203 cited
- → mTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eukaryotic Translation Initiation Factor 4E(2003)871 cited
- → Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling(2002)827 cited
- → Hypoxia-inducible Factor 1α Is Regulated by the Mammalian Target of Rapamycin (mTOR) via an mTOR Signaling Motif(2007)489 cited
- → mTOR and autophagy: A dynamic relationship governed by nutrients and energy(2014)431 cited
- → mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3(2014)375 cited
- → The Tuberous Sclerosis Protein TSC2 Is Not Required for the Regulation of the Mammalian Target of Rapamycin by Amino Acids and Certain Cellular Stresses(2005)355 cited
- → Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning(2006)353 cited
- → mTOR, translational control and human disease(2005)316 cited